AVIEW Lung Nodule CAD vs ClearRead CT
AI Verdict
Choose AVIEW Lung Nodule CAD if…
Choose AVIEW Lung Nodule CAD if your practice requires a comprehensive AI solution for simultaneous screening of lung cancer, COPD, and coronary artery calcification from a single chest CT. This tool is ideal for facilities seeking detailed quantitative emphysema analysis and automated Lung-RADS report generation to streamline multi-faceted diagnostic workflows.
View AVIEW Lung Nodule CAD →Choose ClearRead CT if…
Choose ClearRead CT if your primary goal is to significantly enhance pulmonary nodule detection accuracy and reduce reading times through advanced AI. Its patented vessel suppression technology is particularly beneficial for radiologists needing to confidently identify subtle nodules often obscured by vasculature, thereby improving diagnostic confidence and workflow efficiency.
View ClearRead CT →When choosing between AVIEW Lung Nodule CAD and ClearRead CT, physicians should consider their primary focus and existing infrastructure. AVIEW Lung Nodule CAD excels in comprehensive quantitative analysis, offering detailed metrics beyond simple nodule detection. It provides 3D nodule size and volume quantification, automatic report generation based on Lung-RADS, and volume doubling time calculations for follow-up. A key differentiator is its simultaneous analysis of lung nodules, emphysema, and coronary artery calcification (the “Big 3”), including quantitative emphysema analysis and various CAC scoring methods. This makes AVIEW ideal for practices seeking a holistic view of cardiothoracic health with extensive quantitative data.
ClearRead CT, on the other hand, prioritizes enhanced nodule detection and workflow efficiency through its patented vessel suppression technology. This unique feature aims to improve diagnostic accuracy by reducing visual clutter, potentially leading to faster reading times and a reduction in missed actionable nodules. While it also offers nodule characterization, measurement, and automated tracking, its core strength lies in its ability to provide clearer images for more confident nodule identification. Therefore, ClearRead CT is better suited for physicians who prioritize optimizing the visual clarity of CT scans for nodule detection and streamlining their reading workflow.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AVIEW Lung Nodule CAD | ClearRead CT |
|---|---|---|
| Pricing | Contact for pricing | Contact for pricing |
| Deployment | Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker) | On-premise (stand-alone server, virtual machine) and Cloud |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
ClearRead CTClearRead CT explicitly highlights 'Reduced Reading Time (up to 36%)' and 'Seamless PACS Integration / Vendor-neutral processing,' which directly address workflow efficiency and ease of adoption within existing radiology environments. Its 'Patented Vessel Suppression' also contributes to clearer images, potentially simplifying the interpretation process for radiologists.
Clinical Value
ClearRead CTWhile both tools offer robust clinical features, ClearRead CT provides a quantifiable clinical benefit with its claim of 'Improved Detection Accuracy (29% reduction in missed actionable nodules).' This specific metric, combined with its 'Patented Vessel Suppression' technology, suggests a direct and significant impact on diagnostic confidence and patient outcomes.
Pricing & Value
TieBoth AVIEW Lung Nodule CAD and ClearRead CT require direct contact with the vendor for pricing details, offering no public transparency. Although Tool A provides a slight hint at potential pricing models (per-case or one-time), there isn't enough specific information to definitively compare their value propositions.
Enterprise Readiness
ClearRead CTClearRead CT emphasizes 'Seamless PACS Integration / Vendor-neutral processing,' which is crucial for smooth deployment and interoperability within complex hospital IT infrastructures. Its mention of operating with the VA and other healthcare institutions also suggests a proven track record in enterprise environments, implying robust security and reliability.
Innovation
ClearRead CTClearRead CT's 'Patented Vessel Suppression (Clear Visual Intelligence)' stands out as a unique technological innovation specifically designed to improve image clarity and enhance nodule detection. While AVIEW Lung Nodule CAD offers comprehensive 'Big 3' simultaneous analysis, the vessel suppression technology represents a more novel and foundational approach to improving diagnostic image quality.
Support & Docs
TieNeither the provided structured facts nor a subsequent web search yielded specific public information regarding customer support channels, service level agreements, or extensive documentation availability for either AVIEW Lung Nodule CAD or ClearRead CT. Therefore, it is not possible to distinguish between the two on this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AVIEW Lung Nodule CAD | ClearRead CT |
|---|---|---|
| Company | Coreline Soft Co. | RIVERAIN TECHNOLOGIES |
| Pulmonary Nodule Detection | AI-based pulmonary nodule detection (3-20 mm) on CT scans | Pulmonary Nodule Detection (solid, part-solid, ground glass) |
| Nodule Classification Types | solid, part-solid, non-solid | solid, part-solid, ground glass |
| Nodule Measurement | 3D nodule size and volume quantification | volume, diameter, location, type, depth |
| Nodule Tracking/Comparison | Nodule matching and volume doubling time (VDT) calculation for follow-up comparisons | Automated Nodule Tracking and Comparison to Prior Exams |
| Coronary Artery Calcification (CAC) Scoring | CAC scoring (Agatston, volume, mass scores) | CAC Scoring (ungated, non-contrast CTs) |
| Additional Key Feature | Quantitative emphysema analysis (e.g., Low Attenuation Area - LAA, emphysema index) | Patented Vessel Suppression (Clear Visual Intelligence) |
Videos
Demos, reviews, and walkthroughs featuring AVIEW Lung Nodule CAD and ClearRead CT.